Enbumyst is not intended for chronic use and should be replaced with oral diuretics as soon as practical. The Food and Drug Administration (FDA) has approved Enbumyst ™, a nasal spray formulation of ...
Please provide your email address to receive an email when new articles are posted on . A nasal spray version of the diuretic bumetanide showed equivalence to oral ...
Bumetanide nasal spray had comparable pharmacodynamic effects of diuresis and natriuresis to IV and oral bumetanide. (HealthDay News) — Bumetanide nasal spray (BNS) has statistical bioequivalence to ...
A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results